Model-based AI to de-risk and accelerate the development of
• DTx ,
• digital biomarkers , and
• digital clinical measures
to be integrated with classical medications making drugs smart.
Bringing preclinical rigor to digital health—fast, explainable, and designed for differentiation and IP protection.
Support for smart combinations and converging regulations.
Harness virtual patients and in silico simulation to design faster, smarter clinical trials for d...
Enhancing Drug Lifecycle Management and Post-Market Optimization.